These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 2314446)
1. Proton nuclear magnetic resonance spectroscopy of plasma from healthy subjects and patients with cancer. Engan T; Krane J; Klepp O; Kvinnsland S N Engl J Med; 1990 Apr; 322(14):949-53. PubMed ID: 2314446 [TBL] [Abstract][Full Text] [Related]
2. Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma. Fossel ET; Carr JM; McDonagh J N Engl J Med; 1986 Nov; 315(22):1369-76. PubMed ID: 3022146 [TBL] [Abstract][Full Text] [Related]
3. Lack of efficacy of water-suppressed proton nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors. Okunieff P; Zietman A; Kahn J; Singer S; Neuringer LJ; Levine RA; Evans FE N Engl J Med; 1990 Apr; 322(14):953-8. PubMed ID: 2314447 [TBL] [Abstract][Full Text] [Related]
4. [NMR research on blood plasma for tumor detection--a method for mass screening?]. Fritzsche H; Sprinz H; Jahn H; Jorke D Arch Geschwulstforsch; 1989; 59(2):129-33. PubMed ID: 2719533 [TBL] [Abstract][Full Text] [Related]
5. An NMR blood test for uveal melanoma? Smith EV; Kolodny NH; Gragoudas ES; Egan KM; Finn S; D'Amico DJ; Seddon JM Invest Ophthalmol Vis Sci; 1990 May; 31(5):993-7. PubMed ID: 2335461 [TBL] [Abstract][Full Text] [Related]
6. Effect of triglyceride levels on methyl and methylene envelope line widths in proton nuclear magnetic resonance spectroscopy of human plasma. Mims MP; Morrisett JD; Mattioli CA; Gotto AM N Engl J Med; 1989 Jun; 320(22):1452-7. PubMed ID: 2716796 [TBL] [Abstract][Full Text] [Related]
7. Proton nuclear magnetic resonance spectroscopy measurements of methylene and methyl line widths in plasma: significant variations with extent of breast cancer, duration of pregnancy and aging. Engan T; Krane J; Kvinnsland S NMR Biomed; 1991 Jun; 4(3):142-9. PubMed ID: 1911102 [TBL] [Abstract][Full Text] [Related]
8. Early changes in the 1H-NMR plasma spectrum in patients following breast surgery. Engan T; Krane J; Søreide JA; Bjerve KS; Kvinnsland S Eur J Surg Oncol; 1993 Apr; 19(2):115-22. PubMed ID: 8491314 [TBL] [Abstract][Full Text] [Related]
9. [NMR-relaxation of blood serum in cancer patients]. Papish EA; Temkina TIa; Kariakina NF Med Radiol (Mosk); 1988 Aug; 33(8):47-50. PubMed ID: 3412139 [TBL] [Abstract][Full Text] [Related]
10. The value of combined use of serum tumour markers and nuclear magnetic spectroscopy of plasma in the detection of pancreatic cancer among patients with jaundice or cholestasis: results from a prospective study. Pasanen PA; Kauppinen R; Eskelinen M; Partanen K; Pikkarainen P; Alhava E Anticancer Res; 1993; 13(3):763-8. PubMed ID: 8317910 [TBL] [Abstract][Full Text] [Related]
11. [H-NMR spectroscopy of plasma cannot be used for cancer screening]. Tran Dinh S; Schlumberger M; Gicquel C; Neumann JM; Hervé M; Turpin G; Parmentier C Bull Cancer; 1988; 75(8):795-800. PubMed ID: 3179513 [TBL] [Abstract][Full Text] [Related]
12. [Prostatic tumors. Detection by proton nuclear magnetic resonance spectroscopy of plasma lipoproteins]. Nabholtz JM; Tremeaux JC; Rossignol A; Farnier M; Gambert P; Briet S; Guerrin J J Urol (Paris); 1989; 95(4):209-12. PubMed ID: 2477463 [TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199 [TBL] [Abstract][Full Text] [Related]
14. Plasma selenium level in cancer patients. Gupta S; Narang R; Krishnaswami K; Yadav S Indian J Cancer; 1994 Sep; 31(3):192-7. PubMed ID: 8557298 [TBL] [Abstract][Full Text] [Related]
15. Dimensions and estimated mechanical characteristics of the humerus after long-term tennis loading. Haapasalo H; Sievanen H; Kannus P; Heinonen A; Oja P; Vuori I J Bone Miner Res; 1996 Jun; 11(6):864-72. PubMed ID: 8725185 [TBL] [Abstract][Full Text] [Related]
17. An analysis of age and family history on outcome after breast-conservation treatment: the University of Pennsylvania experience. Haas JA; Schultz DJ; Peterson ME; Solin LJ Cancer J Sci Am; 1998; 4(5):308-15. PubMed ID: 9815295 [TBL] [Abstract][Full Text] [Related]
18. Nuclear magnetic resonance study of cancer: systemic effect on the proton relaxation times (T1 and T2) of human serum. de Certaines J; Bernard AM; Benoist L; Rivet P; Gallier J; Morin P Cancer Detect Prev; 1981; 4(1-4):267-71. PubMed ID: 7349785 [TBL] [Abstract][Full Text] [Related]
19. [Progress in nuclear magnetic resonance spectroscopy for early cancer diagnosis]. Gao XX; Xu YZ; Zhao MX; Qi J; Li HZ; Wu JG Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Aug; 28(8):1942-50. PubMed ID: 18975839 [TBL] [Abstract][Full Text] [Related]
20. Use of proton nuclear magnetic resonance spectroscopy of plasma in screening for malignant disease. Ono S; Moriyasu F; Nabeshima M; Kajimura K; Yamashita Y; Kimura T; Someda H; Hamato N; Okuma M; Ozawa K Cancer; 1992 Sep; 70(6):1638-46. PubMed ID: 1325278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]